IDEAYA Biosciences, Inc. (IDYA) vs Viking Therapeutics, Inc. (VKTX)
A side-by-side comparison of IDEAYA Biosciences, Inc. and Viking Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IDYA
IDEAYA Biosciences, Inc.
$36.63HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VKTX
Viking Therapeutics, Inc.
$28.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IDYA vs VKTX
growth of $100 · dividends reinvested · last 7yIDYA +240.1% (+19.1%/yr)VKTX +238.9% (+19.0%/yr)IDYA compounded faster over this window
IDYA VKTX
IDYA vs VKTX: by the numbers
- •IDYA is the larger company ($3.48B vs $3.31B market cap).
- •Both run net losses; VKTX's is the smaller (0.00% vs -74.75% net margin).
Metrics side by side
Valuation
| Metric | IDYA | VKTX |
|---|---|---|
| P/S ratio | 14.88 | N/A |
| P/B ratio | 2.91 | 8.11 |
Profitability
| Metric | IDYA | VKTX |
|---|---|---|
| Gross margin | -43.89% | 0.00% |
| Operating margin | -72.84% | 0.00% |
| Net margin | -74.75% | 0.00% |
| ROE | -14.60% | -130.98% |
| ROIC | -17.68% | -135.85% |
Growth (annualized)
| Metric | IDYA | VKTX |
|---|---|---|
| Revenue CAGR (5Y) | 45.80% | N/A |
| Total return CAGR (5Y) | 7.32% | 37.36% |
Frequently asked
- How have IDYA and VKTX total returns compared?
- Over the past 5 years, IDYA delivered 7.32% and VKTX delivered 37.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
IDEAYA Biosciences ROEViking Therapeutics ROEIDEAYA Biosciences operating marginViking Therapeutics operating marginIDEAYA Biosciences revenue growthViking Therapeutics revenue growthIDEAYA Biosciences free cash flowViking Therapeutics free cash flow
IDEAYA Biosciences & Viking Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.